Screen Shot 2017-03-08 at 12.04.35 pm

After its recent huge revenue beat & subsequent ramp up, $EAS is taking a breather. Its leading research on colorectal cancer screening has created alot of interest recently.

Its 2017 support line is clearly defined, therefore trade according to its uptrend resumption or a breakdown of 2017 support.